The short version
11 companies supply this market — deep enough that no single failure threatens the supply.
Market view
amphotericin b
33 marketed package NDCs · 11 active manufacturers
Most dispensed: 50 mg · Injectable, Liposomal · #1 vial, single-dose/carton / 1 injectable, liposomal in 1 vial, single-dose
What changed in the last 90 days
Every detected change for amphotericin b, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- AmBisomeAug 12, 2026Mfr exitedAstellas Pharma US, Inc. · amphotericin b
Same drug class
Other molecules FDA puts in Polyene Antifungal, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Amphotericin b in shortage right now?
- No. FDA does not currently list Amphotericin b in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Amphotericin b?
- 11 companies have marketed Amphotericin b in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.